CURRENT PHARMACOLOGY REPORTS
SPRINGERNATURE · GB · Est. 2015
✓ Indexed in the Web of Science Core Collection (ESCI) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.
See the official Impact Factor & quartile on the journal’s page ↗The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q3. Source: Clarivate Journal Citation Reports.
Aims & Scope
This journal presents incisive reviews by international experts, on all aspects of pharmacology, including drug discovery and development. Coverage spans such key subjects as epigenetics and epigenomics, chemoinformatics, rational drug design and target discovery, drug delivery and biomaterial, pharmacogenomics and molecular targets and biomarkers, chemical/drug/molecular toxicology, absorption, distribution, metabolism and elimination (ADME), pharmacokinetics and pharmacodynamics, modeling & simulation and pharmacometrics, and related topics in disease, including neurology and the central nervous system, cardiovascular disease, metabolic diseases, cancer and others.
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.
Subject Classification
Web of Science Categories
Research Topics (OpenAlex)
Frequently asked questions about CURRENT PHARMACOLOGY REPORTS
Is CURRENT PHARMACOLOGY REPORTS a predatory journal?
PubScope has no integrity flags on record for CURRENT PHARMACOLOGY REPORTS: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.
What is the impact factor of CURRENT PHARMACOLOGY REPORTS?
CURRENT PHARMACOLOGY REPORTS is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 2.29.
Is CURRENT PHARMACOLOGY REPORTS indexed in Scopus and Web of Science?
CURRENT PHARMACOLOGY REPORTS is indexed in Web of Science, Scopus.
What is the aims and scope of CURRENT PHARMACOLOGY REPORTS?
This journal presents incisive reviews by international experts, on all aspects of pharmacology, including drug discovery and development. Coverage spans such key subjects as epigenetics and epigenomics, chemoinformatics, rational drug design and target discovery, drug delivery and biomaterial, pharmacogenomics and molecular targets and biomarkers, chemical/drug/molecular toxicology, absorption, distribution, metabolism and elimination (ADME), pharmacokinetics and pharmacodynamics, modeling & simulation and pharmacometrics, and related topics in disease, including neurology and the central ner
You May Also Like
See all →Data updated: 2026-05-26 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref